MARKHAM, Ontario, July 14, 2023 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a "Common Share") for the month of July 2023, representing $0.936 per Common Share on an annualized basis.
The dividend will be payable on August 15, 2023 to shareholders of record as at July 31, 2023.
The Company's dividends are designated as eligible dividends for Canadian tax purposes in accordance with subsection 89(14) of the Income Tax Act (Canada), and any applicable corresponding provincial and territorial legislation.
About Sienna Senior Living
Sienna Senior Living Inc. (TSX:SIA) offers a full range of seniors' living options, including independent living and assisted living under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna's approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit www.siennaliving.ca.
For further information, please contact: David Hung Chief Financial Officer & Executive Vice President (905) 489-0258 [email protected]
A recent article published in the Health News Tribune offers profound insights into the critical role of preventative medicine in securing long-term health, featuring Dr. Gregory Duhon, MD, as a leading voice in this essential discourse. Titled...
The Prime Minister, Justin Trudeau, today announced he will travel to Philadelphia, Pennsylvania, on May 21, 2024, to participate in the Service Employees International Union (SEIU) Quadrennial North American Convention and promote the Canada-US...
REVIAN Inc., an aesthetic medical technology company using precise wavelengths of LED light to rejuvenate hair and skin, announced an upcoming presentation at the 2024 Society for Investigative Dermatology Annual Meeting being held in Dallas on May...
SprintRay, the market leader in dental 3D printing, revealed the latest in their line of desktop 3D printers, Pro 2, along with two new resins from the Company's BioMaterial Innovation Lab - a direct-print Retainer, and a next-gen Dental Model resin....
During Mental Health Month, a critical time for advancing understanding and reducing stigma around mental health, renowned EdTech entrepreneur and executive coach Liana Habicht unveils Recalibrate. This new program from Connected Method not only...
CardioPharma Inc. (the "Company"), a specialty pharmaceutical company focused on drug development for cardiovascular diseases, announced that on August 29, 2023, the United States Patent and Trademark Office ("USPTO") issued US Patent 11,737,988 B2...
